Author

Elizabeth Tinney

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

OpenAlex ID: A5049010015

Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties

2007 · Jun Wang, Srinivas Kodali, et al. · Proceedings of the National Academy of Sciences · 382

Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants

2009 · Dai-Shi Su, John J. Lim, et al. · Bioorganic & Medicinal Chemistry Letters · 44

Biaryl Ethers as Novel Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Key Mutant Viruses

2009 · Dai-Shi Su, John J. Lim, et al. · Journal of Medicinal Chemistry · 36

Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: Aryl substituted pyrazole as a surrogate for the pyrazolopyridine motif

2010 · Dai-Shi Su, John J. Lim, et al. · Bioorganic & Medicinal Chemistry Letters · 16

2-Aminobenzophenones as a Novel Class of Bradykinin B1Receptor Antagonists

2008 · Dai-Shi Su, John L. Lim, et al. · Journal of Medicinal Chemistry · 16

Strategies towards Improving the Pharmacokinetic Profile of ε‐Substituted Lysinol‐Derived HIV Protease Inhibitors

2010 · Hemaka A. Rajapakse, Abbas M. Walji, et al. · ChemMedChem · 7

Works count: 6

Citation count: 501

H-index: 6

I10-index: 5